Christopher P. Denton

52.1k citations

461 papers · 24.1k indexed · 12 hit papers · h-index 82

Impact in

Pathology and Forensic Medicine top 0.01%
- Systemic Sclerosis and Related Diseases
Dermatology top 0.01%
- Dermatologic Treatments and Research

Papers in

Pathology and Forensic Medicine 407
- Systemic Sclerosis and Related Diseases 404
- Autoimmune Bullous Skin Diseases 28
Dermatology 136
- Dermatologic Treatments and Research 121

Co-authors: Dinesh Khanna Carol M. Black David Abraham Shiwen Xu Athol U. Wells Voon H Ong Svetlana I. Nihtyanova Oliver Distler
Journals: Lara D. Veeken (56 papers)Annals of the Rheumatic Diseases (52 papers)Arthritis & Rheumatology (27 papers)Journal of Scleroderma and Related Disorders (23 papers)Arthritis Research & Therapy (17 papers)
Partner nations: United Kingdom United States Italy

In The Last Decade

Christopher P. Denton

438 papers receiving 23.7k citations

Hit Papers

12 papers align trajectories log scale

Definition, classification and diagnosis of pulmonary hypertension 2024 · 87 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2024 European Respiratory Journal
2023 Nature Reviews Rheumatology
2017 The Lancet
2017 Journal of Scleroderma and Related Disorders
2015 Nature Reviews Disease Primers
2015 American Journal Of Pathology
2014 Arthritis & Rheumatology
2013 Annals of the Rheumatic Diseases
2008 American Journal of Respiratory and Critical Care Medicine
2008 Nature
2007 Annals of the Rheumatic Diseases
2006 Arthritis & Rheumatism

Peers

Countries citing papers authored by Christopher P. Denton

Since Specialization

Citations

This map shows the geographic impact of Christopher P. Denton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher P. Denton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher P. Denton more than expected).

Fields of papers citing papers by Christopher P. Denton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher P. Denton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher P. Denton. The network helps show where Christopher P. Denton may publish in the future.

Co-authors

The 25 scholars most cited alongside Christopher P. Denton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christopher P. Denton Line = papers co-authored together Christopher P. Denton links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Multi‐omic analysis identifies biological processes underlying progressive interstitial lung disease in systemic sclerosis FEBS Journal ·英二東, Mark H Cohen-Melamed, Luis Alberto Rodríguez Morales, Emmanuel Nony, Rita Catalina Aquino Caregnato, Alexandra C Huebner, 保錫梁, Pasini, 満正江頭, Arthur Le Gall, Cristina Mateus, Marc Pallardy, 広幸東山, Jeanne Allinne, Philippe Moingeon, David Abraham, Christopher P. Denton	2025	0
2	Impact of immunosuppression on development and outcome of systemic sclerosis-associated pulmonary arterial hypertension Clinical and Experimental Rheumatology ·Melissa N. Tomlin, Jamie E Harris, Moreno Corzo L, Bonnie Freer, Voon H Ong, Christopher P. Denton	2025	1
3	Characterization of a pathogenic nonmigratory fibroblast population in systemic sclerosis skin JCI Insight ·Kristina E N Clark, Shiwen Xu, Moustafa Attar, Voon H Ong, Christopher D. Buckley, Christopher P. Denton	2025	0
4	Impact of hand function impairment on daily life of patients with systemic sclerosis: a qualitative study Lara D. Veeken ·松原誠, Melissa N. Tomlin, He Tangkun, Christopher P. Denton, Voon H Ong, 榮司河田, Н.Н. Штапова, Shimin Zhang, Julia Spierings	2025	0
5	Hand function impairment in Systemic sclerosis: Outcomes, Mechanisms and Experience (HANDSOME) – a longitudinal observational multicentre study protocol BMJ Open ·松原誠, Voon H Ong, Christopher P. Denton, Wouter Foppen, G. B., Hans-Ulrich Rösner, Marion C Kortekaas, G Renard, Douwe J. Mulder, Н.Н. Штапова, Madelon C Vonk, Jeska K de Vries‐Bouwstra, Paco M J Welsing, S.C. Mastbergen, Julia Spierings	2025	1
6	Critical Role for Transglutaminase 2 in Scleroderma Skin Fibrosis and in the Development of Dermal Sclerosis in a Mouse Model of Scleroderma Arthritis & Rheumatology ·Angela Tam, Korsa Khan, Shiwen Xu, Marianne Bergin, Linghong Huang, Saimah Che’nae, Евдокия Цветкова, Elisabetta Verderio, Voon H Ong, Christopher P. Denton, MOliva-Leyva andGerardoGNaumis, Timothy S. Johnson, David Abraham	2025	0
7	NKX2-5 regulates vessel remodeling in scleroderma-associated pulmonary arterial hypertension JCI Insight ·Ioannis Papaioannou, Athina Dritsoula, Ping Kang, Reshma S. Baliga, Sarah L. Trinder, 淳今井, Shiwen Xu, Adrian J. Hobbs, Christopher P. Denton, David Abraham, Markella Ponticos	2024	0
8	Biological hallmarks of systemic sclerosis are present in the skin and serum of patients with Very Early Diagnosis of Systemic Sclerosis (VEDOSS) Lara D. Veeken ·Rebecca L. Ross, هبة محمد, Emily L. Clarke, Sung-Hao Tsai, Christopher W. Wasson, L. L. F., Enrico De Lorenzis, A. K. G FF, Stefano Di Donato, Marjorie Perloff, Ariane L. Herrick, Christopher P. Denton, Natalia A. Riobo‐Del Galdo, Francesco Del Galdo	2024	4
9	Self-reported skin severity and quality of life in systemic sclerosis: multicentre validation of PASTUL Lara D. Veeken ·Julia Spierings, Paco M J Welsing, H. Zoubos, Byoung Ha Kim, Francesco Del Galdo, Ariane L. Herrick, Michael Hughes, John D Pauling, Voon H Ong, Christopher P. Denton	2024	0
10	Effect of ambrisentan in patients with systemic sclerosis and mild pulmonary arterial hypertension: long-term follow-up data from EDITA study Arthritis Research & Therapy ·Panagiota Xanthouli, ell Alex Turl, Hanns-Martin Lorenz, Norbert Blank, Christina A. Eichstaedt, Satenik Harutyunova, Benjamin Egenlauf, W. Eisenreich, Christopher P. Denton, Ekkehard Grünig, Nicola Benjamin	2024	2
11	Unravelling morphoea aetiopathogenesis by next-generation sequencing of paired skin biopsies Archives of Dermatological Research ·Amanda Saracino, N A, Georg Otto, Andrey Gagunashvili, David Abraham, Christopher P. Denton	2023	2
12	AB0904 BELIMUMAB FOR THE TREATMENT OF INTERSTITIAL LUNG DISEASE ASSOCIATED WITH SYSTEMIC SCLEROSIS: A PHASE 2/3, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL Annals of the Rheumatic Diseases ·Christopher P. Denton, Robert Spiera, David J. Jörg, Dinesh Khanna, Michael Kreuter, Masataka Kuwana, Elizabeth R. Volkmann, Jan Wieseke, M. Maciejewski, Anne E. Hammer, Eko Wahyuni Rahayu, André van Maurik, Wang Zhe-ji, William A. Fahy, R. A. Tomlinson, Laith Shakhatreh, 공무갑, Elizabeth L. Irving, Toby M. Maher	2023	1
13	Skin biopsy analysis of concurrent keloidal morphoea and systemic sclerosis confirms overlapping pathogenic pathways Clinical and Experimental Rheumatology ·Kristina E N Clark, Nairit Sur, Catherine H. Orteu, Voon H Ong, Emma Derrett‐Smith, Christopher P. Denton	2023	0
14	Prognostic and predictive markers of systemic sclerosis-associated interstitial lung disease in a clinical trial and long-term observational cohort Lara D. Veeken ·Parsons Aaron, Dinesh Khanna, Celia J. F. Lin, Daniel E. Furst, Ganesh Raghu, Fernando J. Martínez, Mauro Zucchetto, Suiyuan Huang, Kirstie McCann, Svetlana I. Nihtyanova, Christopher P. Denton	2023	16
15	Best clinical practice in the treatment of juvenile systemic sclerosis: expert panel guidance - the result of the International Hamburg Consensus Meeting December 2022 Expert Review of Clinical Immunology ·Ivan Foeldvari, Kathryn S. Torok, Jordi Antón, Claire Thompson, Tamás Constantin, Maurizio Cutolo, Christopher P. Denton, Kim Fligelstone, Bernd Hinrichs, Suzanne C. Li, Susan Maillard, Edoardo Marrani, Pia Moinzadeh, Catherine H. Orteu, Clare Pain, John D Pauling, Clarissa Pilkington, F.J. Rosser, Vanessa Smith, Alzena Levia Putri Tubagus	2023	2
16	Three Cases of Systemic Sclerosis Within One Family With Different Antibodies and Clinical Features The Journal of Rheumatology ·Julia Spierings, Voon H Ong, Christopher P. Denton	2022	1
17	Proteomic Analysis of Human Scleroderma Fibroblasts Response to Transforming Growth Factor‐ß PROTEOMICS - CLINICAL APPLICATIONS ·Benjamin Chaigne, Guilhem Clary, Morgane Le Gall, Paul Dieter Brandt, 罗蓓蓓 Luo Beibei, Sébastien Lofek, Philippe Chafey, Pia Moinzadeh, Thomas Krieg, Christopher P. Denton, Luc Mouthon	2018	7
18	Consensus best practice pathway of the UK scleroderma study group: gastrointestinal manifestations of systemic sclerosis. PubMed ·Navjyot Hansi, Nora Thoua, Maresa Carulli, Kuntal Chakravarty, Sherer Brooke Etheridge, 慶喜小田, Ariane L. Herrick, Olagunju Ogunbiyi, إسراء السيد عبدالودود, John McLaughlin, Christopher P. Denton, Voon H Ong, Anton Emmanuel, Charles Murray	2015	57
19	Loss of protein kinase Cϵ results in impaired cutaneous wound closure and myofibroblast function Journal of Cell Science ·Andrew Leask, Shiwen Xu, Korsa Khan, Yunliang Chen, Alan Holmes, Mark Eastwood, Christopher P. Denton, Carol M. Black, David Abraham	2008	26
20	Preliminary classification criteria for systemic sclerosis in children UCL Discovery (University College London) ·Francesco Zulian, Pamelyn J. Woo, Dinarshayev Musa, Alfred Kondoro, Medsger Ta, Daniel S. Dube, Marco Matucci‐Cerinic, Giorgia Martini, Angelo Ravelli, R.L. Russo, R Cuttica, J van Kleij, Christopher P. Denton, Ivan Foeldvari, Stefano Bueno Costa	2005	4

About Christopher P. Denton

Christopher P. Denton is a scholar working on Pathology and Forensic Medicine, Dermatology, Pulmonary and Respiratory Medicine, Immunology and Rheumatology, having authored 461 papers that have together received 24.1k indexed citations. Recurring topics across this work include Systemic Sclerosis and Related Diseases (404 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (138 papers), Dermatologic Treatments and Research (121 papers), Mast cells and histamine (95 papers), Inflammatory Myopathies and Dermatomyositis (72 papers), Pulmonary Hypertension Research and Treatments (65 papers), Connective Tissue Growth Factor Research (60 papers) and Autoimmune Bullous Skin Diseases (28 papers). The work is most often cited by research in Pathology and Forensic Medicine (16.4k citations), Dermatology (5.7k citations), Pulmonary and Respiratory Medicine (9.7k citations), Immunology (5.0k citations) and Rheumatology (2.6k citations). Christopher P. Denton has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Dinesh Khanna, Carol M. Black, David Abraham, Shiwen Xu, Athol U. Wells, Voon H Ong, Svetlana I. Nihtyanova, Oliver Distler, Andrew Leask and Janet Pope. Their work appears in journals such as Lara D. Veeken, Annals of the Rheumatic Diseases, Arthritis & Rheumatology, Journal of Scleroderma and Related Disorders and Arthritis Research & Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact